Used as a key intermediate in the synthesis of pharmaceutical agents targeting central nervous system disorders. Particularly valuable in developing dopamine receptor agonists for the treatment of Parkinson’s disease. Its chiral structure enables selective interaction with biological targets, improving drug efficacy and reducing side effects. Also investigated for use in neuroprotective agents due to its ability to cross the blood-brain barrier efficiently. Employed in research settings to design novel therapeutics for neurodegenerative conditions and psychiatric disorders involving dopaminergic pathways.